Photo: Ars Technica
Technology
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
TL;DR
- The risk appears small and data is mixed, but FDA wants patients to be aware.
Short summary
Our full write-up is on its way. For the complete story, read the original report:
Nov 10, 2026 · Updated 11/10/2026, 3:28:15 PM · Reported with: Ars Technica
Sources (1)
NRI Bytes writes its own articles from the reporting below.
Ars Technica — FDA warns GLP-1 drugs may pose risk of rare condition that causes vision lossUp next · Technology
T-Mobile illegally imposed 50 GB cap on low-income home Internet plan, NY says
Read next →
More stories
Technology
Why the data center you dread might never even be built
2h ago
Technology
Meta is losing its longtime head of infrastructure
2h ago
Technology
Olaf Sakkers is betting he can beat the emerging-manager squeeze
2h ago
Technology
CoreWeave turns to customer prepayments, shorter contracts to fund AI growth
2h ago
